LA
GILD icon

Legacy Advisors’s Gilead Sciences GILD Stock Holding History

Legacy Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,386
Closed -$491K – 167
2025
Q1 		$491K Buy
4,386
+522
+14% +$53.9K 0.05% 265
2024
Q4 		$357K Buy
3,864
+870
+29% +$78.3K 0.03% 289
2024
Q3 		$251K Buy
+2,994
New +$228K 0.03% 326
2024
Q1 		– Sell
-2,668
Closed -$216K – 322
2023
Q4 		$216K Buy
+2,668
New +$208K 0.03% 287
2021
Q1 		– Sell
-5,416
Closed -$316K – 124
2020
Q4 		$316K Hold
5,416
– – 0.18% 81
2020
Q3 		$342K Sell
5,416
-584
-10% -$40.5K 0.23% 72
2020
Q2 		$462K Buy
+6,000
New +$460K 0.37% 56
2019
Q3 		– Sell
-550
Closed -$37K – 193
2019
Q2 		$37K Buy
+550
New +$36.2K 0.03% 222
2018
Q4 		– Sell
-130
Closed -$10K – 219
2018
Q3 		$10K Hold
130
– – ﹤0.01% 349
2018
Q2 		$9K Buy
130
+55
+73% +$3.88K 0.01% 312
2018
Q1 		$6K Hold
75
– – ﹤0.01% 295
2017
Q4 		$5K Hold
75
– – ﹤0.01% 299
2017
Q3 		$6K Hold
75
– – 0.01% 265
2017
Q2 		$5K Hold
75
– – 0.01% 179
2017
Q1 		$5K Sell
75
-355
-83% -$25K 0.01% 171
2016
Q4 		$30K Buy
+430
New +$32K 0.04% 128

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legacy Advisors's GILD Position: Q2 2025 in Review

Legacy Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 4,386 shares — an estimated $491K sold.

Legacy Advisors first reported a position in GILD in Q4 2016 and held it in 16 quarters. The position peaked at $491K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Legacy Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Legacy Advisors sold 4,386 Gilead Sciences shares in Q2 2025, an estimated $491K.
  • Legacy Advisors first reported a position in Gilead Sciences in Q4 2016 and held it in 16 quarters.
  • Legacy Advisors's Gilead Sciences position peaked at $491K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Legacy Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.